Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Daiichi Sankyo
Colorcon
Moodys
Federal Trade Commission
Fuji
Deloitte
Julphar

Generated: April 23, 2018

DrugPatentWatch Database Preview

ABREVA Drug Profile

« Back to Dashboard

When do Abreva patents expire, and when can generic versions of Abreva launch?

Abreva is a drug marketed by Glaxosmithkline and is included in one NDA.

The generic ingredient in ABREVA is docosanol. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the docosanol profile page.
Drug patent expirations by year for ABREVA
Synonyms for ABREVA
1-DOCOSANOL
1-Docosanol (Behenyl alcohol)
1-Docosanol, 98%
1-Docosanol, purum, >=97.0% (GC)
2793-EP2374787A1
30303-65-2
33906-EP2275420A1
33906-EP2295055A2
33906-EP2295416A2
33906-EP2298748A2
33906-EP2298764A1
33906-EP2298765A1
33906-EP2305642A2
33906-EP2311453A1
33906-EP2311808A1
33906-EP2311829A1
4-01-00-01906 (Beilstein Handbook Reference)
661-19-8
9G1OE216XY
A3D72D45-625E-49B5-B0FC-394010B3485D
A8416
AB01563123_01
AB01563123_02
AB2000182
Abreva (TN)
AC-19852
AC1L1ZZI
AC1Q2W4M
AC1Q7CQ8
ACMC-1CMUG
AI3-36489
AK113719
AKOS015902887
AM20100601
AN-20480
ANW-35147
API0002466
API0015199
AX8022073
Behenic alcohol
behenic alcohol;
Behenyl alcohol
BEHENYL ALCOHOL, 98%
Behenyl alcohol, Abreva, 1-Docosanol, Docosanol
Behenyl alcohol, AI3-36489, Behenic alcohol, 1-Docosanol, Docosyl alcohol, IK-2, Tadenan
Behenyl alcohol;Abreva;1-Docosanol;Abreva
BRN 1770470
C-33691
C22 Alcohol
C22H46O
Cachalot BE-22
CAS-661-19-8
CC-04445
CCG-213539
CCRIS 8943
CHEBI:31000
CHEMBL1200453
CTK1C3756
D00AOJ
D03884
D0964
DB00632
Debat
Doconsanol
docosan-1-ol
Docosanol
Docosanol (Abreua)
Docosanol (Abreva)
Docosanol (USAN)
Docosanol (VAN)
Docosanol [USAN]
Docosanol-(1)
docosanyl alcohol
Docosyl alcohol
DSSTox_CID_7286
DSSTox_GSID_27286
DSSTox_RID_78387
DTXSID4027286
EBD35098
EINECS 211-546-6
Emery 3304
Erazaban
Erazaban (TN)
FT-0622609
Healip
Herepair
HMS2093P22
HSDB 5739
HY-B0222
I14-19460
IK 2
IK.2
InChI=1/C22H46O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23/h23H,2-22H2,1H
K949
KB-251719
KS-000015DV
Lanette 22
Lidakol
Lidavol
LMFA05000008
Loxiol VPG 1451
LP084562
LS-174295
LS-63381
MCULE-3239333381
MFCD00002939
MolPort-003-666-887
n-Docosanol
NAA 422
Nacol 22-97
NCGC00159370-02
NCGC00159370-03
NCGC00159370-04
NCGC00159370-05
NOPFSRXAKWQILS-UHFFFAOYSA-N
NSC 8407
NSC-759235
NSC-8407
NSC759235
NSC8407
Pharmakon1600-01505729
RTR-022408
s1637
SBB060170
SBI-0206938.P001
SC-15883
SCHEMBL51925
SR-05000001915
SR-05000001915-1
ST24024751
ST51046404
Stenol 1822
Stenol 1822A
Tadenan
TL8004688
Tox21_111611
TR-022408
TRA0024733
UNII-9G1OE216XY
UNII-B1K89384RJ component NOPFSRXAKWQILS-UHFFFAOYSA-N
UNII-O4M0347C6A component NOPFSRXAKWQILS-UHFFFAOYSA-N
V-1326
ZINC6920384

US Patents and Regulatory Information for ABREVA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline ABREVA docosanol CREAM;TOPICAL 020941-001 Jul 25, 2000 OTC Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ABREVA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline ABREVA docosanol CREAM;TOPICAL 020941-001 Jul 25, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline ABREVA docosanol CREAM;TOPICAL 020941-001 Jul 25, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Dow
AstraZeneca
Deloitte
Chubb
Queensland Health
Healthtrust
Daiichi Sankyo
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.